- For 1H24, Raffles Medical Group (SGX:BSL) reported lower y-o-y revenue (-1.4% y-o-y) due to the absence of COVID-19-related revenue but higher revenue on a sequential basis (+8.8% h-o-h), driven by better revenue contributions from the hospital services and insurance segments.
Results slightly below expectations.
- - Read this at SGinvestors.io -
- The underperformance was due to lower margins from higher operating expenses and lower-than-expected other operating income (-S$6m y-o-y). The lower other operating income was largely due to lower Wage Credit payout and Jobs Growth Incentive grant received in 1H24.
- - Read this at SGinvestors.io -
Softer but stabilising margins.
- 1H24 EBITDA (-9.0ppt y-o-y, -0.6ppt h-o-h) and PATMI (- 7.8ppt y-o-y, -0.6ppt h-o-h) margins were softer due to the absence of higher-margin COVID-19 revenue, increased insurance expenses and operating expenses.
- 1H24 staff costs was largely stable (+0.2ppt y-o-y, +0.7ppt h-o-h) at 42% of turnover. However, driven by the ongoing shortage of nurses in Singapore, we expect staff costs as a percentage of turnover to normalise closer to the historical pre-pandemic level of 50% moving forward.
Healthcare services: Strong sequential performance and improved outlook.
- Read more at SGinvestors.io.
Above is an excerpt from a report by UOB Kay Hian Research.
Clients of UOB Kay Hian may be the first to access the full PDF report @ https://www.utrade.com.sg/.
Llelleythan Tan UOB Kay Hian Research | Heidi Mo UOB Kay Hian | https://research.uobkayhian.com/ 2024-07-30
Read also UOB's most recent report:
2025-02-25 Raffles Medical - 2024 Results In Line; Share Buyback Announced.
Price targets by 4 other brokers at Raffles Medical Target Prices.
Listing of research reports at Raffles Medical Analyst Reports.
Relevant links:
Raffles Medical Share Price History,
Raffles Medical Announcements,
Raffles Medical Dividend Payout Dates & Corporate Actions,
Raffles Medical News